ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.
With a ceasefire between Israel and Lebanese militants Hezbollah appearing in tatters, aid agencies warn that a resumption of ...
Growth was led by the L5 segment, which expanded nearly 4% to 25,307 units, even as the L3 category declined about 1% to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results